Clinical Trial Update: Description of Patients With Type 1 Diabetes Treated With Teplizumab

View source ↗

Summary

Completed trial update detailing patient characteristics and outcomes in individuals with Type 1 diabetes treated with teplizumab.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Teplizumab (Teplizumab)

Snippet

Sponsor: Sanofi | Conditions: Type 1 Diabetes | Status: COMPLETED